Drug Designing: Open Access

Drug Designing: Open Access
Open Access

ISSN: 2169-0138

Citations Report

Citations Report - Drug Designing: Open Access [127 Articles]

The articles published in Drug Designing: Open Access have been cited 127 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Drug Designing: Open Access.

Jian C, Zhang P, Ma J, Jian S, Zhang Q, Liu B, et al. The roles of fatty-acid modification in the activity of the anticancer peptide R-lycosin-I. Molecular pharmaceutics. 2018;15: 4612-20.

Shoombuatong W, Schaduangrat N, Nantasenamat C. Unraveling the bioactivity of anticancer peptides as deduced from machine learning. EXCLI journal. 2018;7: 734.

Gelain A, Mori M, Meneghetti F, Villa S. Signal transducer and activator of transcription protein 3 (STAT3): An update on its direct inhibitors as promising anticancer agents. Current medicinal chemistry. 2019.

Beebe JD, Liu JY, Zhang JT. Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?. Pharmacology & therapeutics. 2018;191: 74-91.

Chen X, Guo L, Ma Q, Chen W, Fan W, Zhang J. Design, Synthesis, and Biological Evaluation of Novel N-Acylhydrazone Bond Linked Heterobivalent β-Carbolines as Potential Anticancer Agents. Molecules. 2019;24 :2950.

Deokar H, Deokar M, Wang W, Zhang R, Buolamwini JK. QSAR studies of new pyrido [3, 4-b] indole derivatives as inhibitors of colon and pancreatic cancer cell proliferation. Medicinal Chemistry Research. 2018 ;27: 2466-81.

Peltek OO, Muslimov AR, Zyuzin MV, Timin AS. Current outlook on radionuclide delivery systems: from design consideration to translation into clinics. Journal of nanobiotechnology. 2019;17: 90.

Kang KW, Song MG. Organic Nanomaterials: Liposomes, Albumin, Dendrimer, Polymeric. Radionanomedicine: Combined Nuclear and Nanomedicine. 2018: 105.

Dias AP, da Silva Santos S, da Silva JV, Parise Filho R, Ferreira EI, El Seoud O, et al. Dendrimers in the context of nanomedicine. International Journal of Pharmaceutics. 2019 : 118814.

Kang KW, Song MG. Organic Nanomaterials: Liposomes, Albumin, Dendrimer, Polymeric Nanoparticles. InRadionanomedicine 2018.

Dias AP, da Silva Santos S, da Silva JV, Parise Filho R, Ferreira EI, El Seoud O, et al. Dendrimers in the context of nanomedicine. International Journal of Pharmaceutics. 2019;20: 118814.

Satarupa M, Aruna V, Gayathri R. Villainous Effect of Sun and Goodness of Evefresh. Skin Diseases & Skin Care. 2017.

Rao MS, Varma YN. Journal of Pharmaceutical and Scientific Innovation.

Kwofie SK, Broni E, Teye J, Quansah E, Issah I, Wilson MD,et al. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24. Computers in biology and medicine. 2019;113: 103414.

Armando R, Mengual Gómez D, Juritz E, Lorenzano Menna P, Gomez D. Homology model and docking-based virtual screening for ligands of human dyskerin as new inhibitors of telomerase for cancer treatment. International journal of molecular sciences. 2018;19: 3216.

Kwofie S, Dankwa B, Odame E, Agamah F, Doe L, Teye J, et al. In silico screening of isocitrate lyase for novel anti-buruli ulcer natural products originating from Africa. Molecules

Pastor-Anglada M, Pérez-Torras S. Who is who in adenosine transport. Frontiers in pharmacology. 2018;9.

Tahlan S, Kumar S, Ramasamy K, Lim SM, Shah SA, Mani V, et al. In-silico molecular design of heterocyclic benzimidazole scaffolds as prospective anticancer agents. BMC chemistry. 2019;13: 90.

Kumar S, Sharma D, Narasimhan B, Ramasamy K, Shah SA, Lim SM, et al. Computational approaches: discovery of GTPase HRas as prospective drug target for 1, 3-diazine scaffolds. BMC chemistry. 2019;13: 96.

Kakkar S, Kumar S, Lim SM, Ramasamy K, Mani V, Shah SA, et al. Design, synthesis and biological evaluation of 3-(2-aminooxazol-5-yl)-2 H-chromen-2-one derivatives. Chemistry Central Journal. 2018;12: 130.

Top